Increase in Credit Facility and Waiver Extension

Summary by AI ^BETAClose X

Litigation Capital Management Limited has increased its credit facility with Northleaf Capital Partners from US$75 million to US$100 million and extended a debt covenant waiver to March 1, 2026. During this extended waiver period, the interest rate on the loan will remain increased by 2.00% per annum, with no additional waiver fee. This extension reflects Northleaf's continued support as LCM progresses its strategic review to resolve its capital position.

Disclaimer*

Litigation Capital Management Ltd

02 February 2026

2 February 2026

Litigation Capital Management Limited

("LCM" or the "Company")

Increase in Credit Facility and Covenant Waiver Extension

Litigation Capital Management Limited ("LCM"), an alternative asset manager specialising in dispute financing solutions internationally, announces that it has to increase its credit facility with funds managed by Northleaf Capital Partners (Canada) Ltd ("Northleaf") from US$75 million to US$100 million. Furthermore, the debt covenant waiver from Northleaf that was due to expire at the end of January 2026 has been extended to 1 March 2026. During the extended waiver period the interest on the loan remains increased by 2.00% per annum consistent with the initial waiver. There is no additional one-time waiver fee in relation to this extension.

The Strategic Review that was first announced on 15 September 2025 continues to progress and this waiver extension is reflective of Northleaf's ongoing support while LCM works towards a long-term resolution of its capital position. LCM management will provide an update on the progress of the Strategic Review in due course.

Enquiries

Litigation Capital Management
Patrick Moloney, Chief Executive Officer David Collins, Chief Financial Officer

Cavendish (Nomad and Broker)	Tel: 020 7220 0500
Jonny Franklin-Adams and Isaac Hooper (Corporate Finance) Tim Redfern (Corporate Broking)

www.lcmfinance.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END